Athyrium Capital Management as of Sept. 30, 2022
Portfolio Holdings for Athyrium Capital Management
Athyrium Capital Management holds 11 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biora Note 7.250% 12/0 (Principal) | 23.5 | $63M | 104M | 0.61 | |
| Amryt Pharma Sponsored ADS | 23.0 | $61M | 8.9M | 6.92 | |
| Caremax Com Cl A | 11.9 | $32M | 4.5M | 7.09 | |
| Rvl Pharmaceuticals SHS (RVLPQ) | 11.5 | $31M | 15M | 2.10 | |
| Omeros Corp Note 5.250% 2/1 (Principal) | 8.4 | $22M | 40M | 0.56 | |
| Omeros Corp Note 6.250%11/1 (Principal) | 7.2 | $19M | 21M | 0.92 | |
| Progenity | 5.4 | $15M | 30M | 0.48 | |
| BridgeBio Pharma Note 2.250% 2/0 (Principal) | 3.3 | $8.7M | 20M | 0.44 | |
| Paratek Pharmaceuticals Note 4.750% 5/0 (Principal) | 3.0 | $8.0M | 9.0M | 0.89 | |
| Puma Biotechnology (PBYI) | 1.6 | $4.2M | 1.8M | 2.37 | |
| Recro Pharma (SCTL) | 1.3 | $3.6M | 2.2M | 1.63 |
